{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:21:17Z","timestamp":1790716877574,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T00:00:00Z","timestamp":1461628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T00:00:00Z","timestamp":1461628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY13574"],"award-info":[{"award-number":["EY13574"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK13574"],"award-info":[{"award-number":["DK13574"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK101373"],"award-info":[{"award-number":["DK101373"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK72517"],"award-info":[{"award-number":["DK72517"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["EB00415"],"award-info":[{"award-number":["EB00415"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008087","name":"Guthy-Jackson Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40478-016-0309-4","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T02:59:40Z","timestamp":1461639580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Clobetasol promotes remyelination in a mouse model of neuromyelitis optica"],"prefix":"10.1186","volume":"4","author":[{"given":"Xiaoming","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Verkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,26]]},"reference":[{"key":"309_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00401-013-1204-8","volume":"127","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Ratelade J, Verkman AS. Unique neuromyelitis optica pathology produced in naive rats by intracerebral administration of NMO-IgG. Acta Neuropath. 2014;127:539\u201351.","journal-title":"Acta Neuropath"},{"key":"309_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/brain\/awn334","volume":"132","author":"AS Baer","year":"2009","unstructured":"Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, Ffrench-Constant C, et al. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain. 2009;132:465\u201381.","journal-title":"Brain"},{"key":"309_CR3","unstructured":"Bahn E HV, Bruck W, Stadelmann C (2015) Axonal damage and loss in multiple sclerosis and neuromyelitis optica. Mult Scler 21 (abstr.)"},{"key":"309_CR4","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/glia.22697","volume":"62","author":"EG Baxi","year":"2014","unstructured":"Baxi EG, Schott JT, Fairchild AN, Kirby LA, Karani R, Uapinyoying P, et al. A selective thyroid hormone beta receptor agonist enhances human and rodent oligodendrocyte differentiation. Glia. 2014;62:1513\u201329.","journal-title":"Glia"},{"key":"309_CR5","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0014-4886(03)00347-9","volume":"184","author":"WF Blakemore","year":"2003","unstructured":"Blakemore WF, Gilson JM, Crang AJ. The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors. Exper Neurol. 2003;184:955\u201363.","journal-title":"Exper Neurol"},{"key":"309_CR6","first-page":"75","volume":"15","author":"M Bradl","year":"2008","unstructured":"Bradl M, Lassmann DH. Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance? Intern MS J\/MS Forum. 2008;15:75\u20138.","journal-title":"Intern MS J\/MS Forum"},{"key":"309_CR7","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","volume":"64","author":"BA Cree","year":"2005","unstructured":"Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology. 2005;64:1270\u20132.","journal-title":"Neurology"},{"key":"309_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12647","volume":"502","author":"VA Deshmukh","year":"2013","unstructured":"Deshmukh VA, Tardif V, Lyssiotis CA, Green CC, Kerman B, Kim HJ, et al. A regenerative approach to the treatment of multiple sclerosis. Nature. 2013;502:327\u201332.","journal-title":"Nature"},{"key":"309_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jneumeth.2012.06.017","volume":"209","author":"TA Dincman","year":"2012","unstructured":"Dincman TA, Beare JE, Ohri SS, Whittemore SR. Isolation of cortical mouse oligodendrocyte precursor cells. J Neurosci Meth. 2012;209:219\u201326.","journal-title":"J Neurosci Meth"},{"key":"309_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.stemcr.2014.05.016","volume":"3","author":"J Ferent","year":"2014","unstructured":"Ferent J, Cochard L, Faure H, Taddei M, Hahn H, Ruat M, et al. Genetic activation of Hedgehog signaling unbalances the rate of neural stem cell renewal by increasing symmetric divisions. Stem Cell Rep. 2014;3:312\u201323.","journal-title":"Stem Cell Rep"},{"key":"309_CR11","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1177\/1352458511432896","volume":"18","author":"BM Greenberg","year":"2012","unstructured":"Greenberg BM, Graves D, Remington G, Hardeman P, Mann M, Karandikar N, et al. Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success. Mult Scler. 2012;18:1022\u20136.","journal-title":"Mult Scler"},{"key":"309_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fneur.2015.00257","volume":"6","author":"DE Harlow","year":"2015","unstructured":"Harlow DE, Honce JM, Miravalle AA. Remyelination therapy in multiple sclerosis. Front Neurol. 2015;6:257.","journal-title":"Front Neurol"},{"key":"309_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nn.2702","volume":"14","author":"JK Huang","year":"2011","unstructured":"Huang JK, Jarjour AA, Nait Oumesmar B, Kerninon C, Williams A, Krezel W, et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci. 2011;14:45\u201353.","journal-title":"Nat Neurosci"},{"key":"309_CR14","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1523\/JNEUROSCI.0137-12.2012","volume":"32","author":"A Ishii","year":"2012","unstructured":"Ishii A, Fyffe-Maricich SL, Furusho M, Miller RH, Bansal R. ERK1\/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination. J Neurosci. 2012;32:8855\u201364.","journal-title":"J Neurosci"},{"key":"309_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.10.013","volume":"170","author":"M Jurynczyk","year":"2005","unstructured":"Jurynczyk M, Jurewicz A, Bielecki B, Raine CS, Selmaj K. Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis. J Neuroimmunol. 2005;170:3\u201310.","journal-title":"J Neuroimmunol"},{"key":"309_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00415-012-6692-2","volume":"260","author":"T Kageyama","year":"2013","unstructured":"Kageyama T, Komori M, Miyamoto K, Ozaki A, Suenaga T, Takahashi R, et al. Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica. J Neurol. 2013;260:627\u201334.","journal-title":"J Neurol"},{"key":"309_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/1352458514566419","volume":"21","author":"D Kremer","year":"2015","unstructured":"Kremer D, Kury P, Dutta R. Promoting remyelination in multiple sclerosis: current drugs and future prospects. Mult Scler. 2015;21:541\u20139.","journal-title":"Mult Scler"},{"key":"309_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ana.22593","volume":"71","author":"K Magalon","year":"2012","unstructured":"Magalon K, Zimmer C, Cayre M, Khaldi J, Bourbon C, Robles I, et al. Olesoxime accelerates myelination and promotes repair in models of demyelination. Ann Neurol. 2012;71:213\u201326.","journal-title":"Ann Neurol"},{"key":"309_CR19","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1093\/brain\/awq177","volume":"133","author":"R Marignier","year":"2010","unstructured":"Marignier R, Nicolle A, Watrin C, Touret M, Cavagna S, Varrin-Doyer M, et al. Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain. 2010;133:2578\u201391.","journal-title":"Brain"},{"key":"309_CR20","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nm.3618","volume":"20","author":"F Mei","year":"2014","unstructured":"Mei F, Fancy SP, Shen YA, Niu J, Zhao C, Presley B, et al. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat Med. 2014;20:954\u201360.","journal-title":"Nat Med"},{"key":"309_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000089621","volume":"2","author":"J Mojsilovic-Petrovic","year":"2005","unstructured":"Mojsilovic-Petrovic J, Arneja A, Kalb RG. Enprofylline protects motor neurons from in vitro excitotoxic challenge. Neurodegen Dis. 2005;2:160\u20135.","journal-title":"Neurodegen Dis"},{"key":"309_CR22","doi-asserted-by":"publisher","first-page":"18061","DOI":"10.1073\/pnas.1411294111","volume":"111","author":"SM Moore","year":"2014","unstructured":"Moore SM, Khalaj AJ, Kumar S, Winchester Z, Yoon J, Yoo T, et al. Multiple functional therapeutic effects of the estrogen receptor beta agonist indazole-Cl in a mouse model of multiple sclerosis. Proc Natl Acad Sci U S A. 2014;111:18061\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"309_CR23","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/glia.20977","volume":"58","author":"S Morisaki","year":"2010","unstructured":"Morisaki S, Nishi M, Fujiwara H, Oda R, Kawata M, Kubo T. Endogenous glucocorticoids improve myelination via Schwann cells after peripheral nerve injury: an in vivo study using a crush injury model. Glia. 2010;58:954\u201363.","journal-title":"Glia"},{"key":"309_CR24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature14335","volume":"522","author":"FJ Najm","year":"2015","unstructured":"Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, et al. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature. 2015;522:216\u201320.","journal-title":"Nature"},{"key":"309_CR25","doi-asserted-by":"publisher","first-page":"e0136221","DOI":"10.1371\/journal.pone.0136221","volume":"10","author":"W Neuhaus","year":"2015","unstructured":"Neuhaus W, Schlundt M, Fehrholz M, Ehrke A, Kunzmann S, Liebner S, et al. Multiple antenatal dexamethasone treatment alters brain vessel differentiation in newborn mouse pups. PLoS One. 2015;10:e0136221.","journal-title":"PLoS One"},{"key":"309_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/jnr.23493","volume":"93","author":"JA Olsen","year":"2015","unstructured":"Olsen JA, Akirav EM. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches. J Neurosci Res. 2015;93:687\u201396.","journal-title":"J Neurosci Res"},{"key":"309_CR27","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/glia.22316","volume":"60","author":"MC Ortega","year":"2012","unstructured":"Ortega MC, Cases O, Merchan P, Kozyraki R, Clemente D, de Castro F. Megalin mediates the influence of sonic hedgehog on oligodendrocyte precursor cell migration and proliferation during development. Glia. 2012;60:851\u201366.","journal-title":"Glia"},{"key":"309_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","volume":"10","author":"MC Papadopoulos","year":"2014","unstructured":"Papadopoulos MC, Bennett JL, Verkman AS. Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol. 2014;10:493\u2013506.","journal-title":"Nat Rev Neurol"},{"key":"309_CR29","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2012;11:535\u201344.","journal-title":"Lancet Neurol"},{"key":"309_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrn3468","volume":"14","author":"MC Papadopoulos","year":"2013","unstructured":"Papadopoulos MC, Verkman AS. Aquaporin water channels in the nervous system. Nat Rev Neurosci. 2013;14:265\u201377.","journal-title":"Nat Rev Neurosci"},{"key":"309_CR31","doi-asserted-by":"publisher","unstructured":"Pedraza CE, Taylor C, Pereira A, Seng M, Tham CS, Izrael M, Webb M (2014) Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase. ASN Neuro 6 doi: 10.1177\/1759091414538134 .","DOI":"10.1177\/1759091414538134"},{"key":"309_CR32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-013-1128-3","volume":"125","author":"PW Phuan","year":"2013","unstructured":"Phuan PW, Zhang H, Asavapanumas N, Leviten M, Rosenthal A, Tradtrantip L, et al. C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropath. 2013;125:829\u201340.","journal-title":"Acta Neuropath"},{"key":"309_CR33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","volume":"12","author":"SJ Pittock","year":"2013","unstructured":"Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, et al. Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol. 2013;12:554\u201362.","journal-title":"Lancet Neurol"},{"key":"309_CR34","doi-asserted-by":"publisher","first-page":"e0144550","DOI":"10.1371\/journal.pone.0144550","volume":"10","author":"G Porcu","year":"2015","unstructured":"Porcu G, Serone E, De Nardis V, Di Giandomenico D, Lucisano G, Scardapane M, et al. Clobetasol and halcinonide act as smoothened agonists to promote myelin gene expression and RxRgamma receptor activation. PLoS One. 2015;10:e0144550.","journal-title":"PLoS One"},{"key":"309_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00401-012-0986-4","volume":"123","author":"J Ratelade","year":"2012","unstructured":"Ratelade J, Zhang H, Saadoun S, Bennett JL, Papadopoulos MC, Verkman AS. Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss. Acta Neuropath. 2012;123:861\u201372.","journal-title":"Acta Neuropath"},{"key":"309_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC. Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain. 2010;133:349\u201361.","journal-title":"Brain"},{"key":"309_CR37","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/brain\/awu358","volume":"138","author":"T Skripuletz","year":"2015","unstructured":"Skripuletz T, Manzel A, Gropengiesser K, Schafer N, Gudi V, Singh V, et al. Pivotal role of choline metabolites in remyelination. Brain. 2015;138:398\u2013413.","journal-title":"Brain"},{"key":"309_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/1097-4547(20010215)63:4<303::AID-JNR1024>3.0.CO;2-A","volume":"63","author":"BR Sperber","year":"2001","unstructured":"Sperber BR, McMorris FA. Fyn tyrosine kinase regulates oligodendroglial cell development but is not required for morphological differentiation of oligodendrocytes. J Neurosci Res. 2001;63:303\u201312.","journal-title":"J Neurosci Res"},{"key":"309_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0165-0270(91)90128-M","volume":"37","author":"L Stoppini","year":"1991","unstructured":"Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Meth. 1991;37:173\u201382.","journal-title":"J Neurosci Meth"},{"key":"309_CR40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/ana.22657","volume":"71","author":"L Tradtrantip","year":"2012","unstructured":"Tradtrantip L, Zhang H, Saadoun S, Phuan PW, Lam C, Papadopoulos MC, et al. Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol. 2012;71:314\u201322.","journal-title":"Ann Neurol"},{"key":"309_CR41","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1126\/science.aad3839","volume":"351","author":"HH Tsai","year":"2016","unstructured":"Tsai HH, Niu J, Munji R, Davalos D, Chang J, Zhang H, et al. Oligodendrocyte precursors migrate along vasculature in the developing nervous system. Science. 2016;351:379\u201384.","journal-title":"Science"},{"key":"309_CR42","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/bpa.12085","volume":"23","author":"AS Verkman","year":"2013","unstructured":"Verkman AS, Phuan PW, Asavapanumas N, Tradtrantip L. Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO. Brain Pathol. 2013;23:684\u201395.","journal-title":"Brain Pathol"},{"key":"309_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/B978-0-12-386015-6.00030-5","volume":"87","author":"J Wang","year":"2011","unstructured":"Wang J, Barak LS, Mook Jr RA, Chen W. Glucocorticoid hedgehog agonists in neurogenesis. Vitamin Horm. 2011;87:207\u201315.","journal-title":"Vitamin Horm"},{"key":"309_CR44","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.1073\/pnas.0910712107","volume":"107","author":"J Wang","year":"2010","unstructured":"Wang J, Lu J, Bond MC, Chen M, Ren XR, Lyerly HK, et al. Identification of select glucocorticoids as smoothened agonists: potential utility for regenerative medicine. Proc Natl Acad Sci U S A. 2010;107:9323\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"309_CR45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-013-1220-8","volume":"127","author":"C Wrzos","year":"2014","unstructured":"Wrzos C, Winkler A, Metz I, Kayser DM, Thal DR, Wegner C, et al. Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions. Acta Neuropath. 2014;127:523\u201338.","journal-title":"Acta Neuropath"},{"key":"309_CR46","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.intimp.2014.06.028","volume":"22","author":"A Yamamoto","year":"2014","unstructured":"Yamamoto A, Kakuta H, Sugimoto Y. Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor gamma agonist in mice. Internat Immunopath. 2014;22:204\u20138.","journal-title":"Internat Immunopath"},{"key":"309_CR47","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/glia.22778","volume":"63","author":"W Yang","year":"2015","unstructured":"Yang W, Xiao L, Li C, Liu X, Liu M, Shao Q, et al. TIP30 inhibits oligodendrocyte precursor cell differentiation via cytoplasmic sequestration of Olig1. Glia. 2015;63:684\u201398.","journal-title":"Glia"},{"key":"309_CR48","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ana.22551","volume":"70","author":"H Zhang","year":"2011","unstructured":"Zhang H, Bennett JL, Verkman AS. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol. 2011;70:943\u201354.","journal-title":"Ann Neurol"},{"key":"309_CR49","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1172\/JCI67554","volume":"123","author":"H Zhang","year":"2013","unstructured":"Zhang H, Verkman AS. Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica. J Clin Invest. 2013;123:2306\u201316.","journal-title":"J Clin Invest"},{"key":"309_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.expneurol.2015.02.006","volume":"266","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Zhang YP, Pepinsky B, Huang G, Shields LB, Shields CB, et al. Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination. Exper Neurol. 2015;266:68\u201373.","journal-title":"Exper Neurol"},{"key":"309_CR51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/cns.12154","volume":"19","author":"S Zhornitsky","year":"2013","unstructured":"Zhornitsky S, Wee Yong V, Koch MW, Mackie A, Potvin S, Patten SB, et al. Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair. CNS Neurosci Therapeut. 2013;19:737\u201344.","journal-title":"CNS Neurosci Therapeut"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-016-0309-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-016-0309-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-016-0309-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-016-0309-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T23:37:41Z","timestamp":1718494661000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-016-0309-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,26]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1186\/s40478-016-0309-4","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,26]]},"assertion":[{"value":"7 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"42"}}